intravenous ketorolac and intravenous morphine for reliving acute pain of renal colic

Comparison of intravenous ketorolac and intravenous morphine for reliving acute pain of renal colic in patients referred to the emergency department double blind randomized clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240527061918N1

Enrollment

400

Registered

2024-06-15

Start date

2024-05-26

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal colic. Calculus of lower urinary tract, unspecified

Interventions

Intervention 1: Intervention group A: receiving intravenous ketorolac with a dose of 30 mg/kg. Intervention 2: Intervention groupB: receiving intravenous morphine at a dose of 0.1 mg/kg.

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients over 18 years old with renal colic pain referring to the hospital People aged 18 to 70 with renal colic admitted to the hospital emergency room

Exclusion criteria

Exclusion criteria: Age above 70 years and below 18 years, pregnancy or breastfeeding, digestive problems Allergy to non-steroidal anti-inflammatory drugs

Design outcomes

Primary

Measure	Time frame
Pain reduction in Renal colic patients based on NRS pain measurement criteria. Timepoint: When the patient enters the study. Method of measurement: NRS pain measurement criteria.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contact.

Birjand University of Medical Sciences

international@bums.ac.ir+98 56 3163 5801

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026